Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q3 2020 · 10-Q
Revenue$496.10M$496.10M+9.8% vs Q3 2019 Net Income-$61.60M-$61.60MN/M vs Q3 2019 EPS Diluted-$1.46-$1.46N/M vs Q3 2019 Operating Income$18,500,000−68.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$19,000,000−50.6% Margins · derivedOperating margin3.7%−9.3 pt vs Q3 2019
Net margin-12.4%−8.9 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 4, 2020 · 35 d after period end